Cocaine Use Disorders Completed Phase 2 Trials for Cycloserine (DB00260)

Also known as: Cocaine Use Disorder

IndicationStatusPhase
DBCOND0032361 (Cocaine Use Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00780442D-Cycloserine and Cue Exposure in Cocaine-Dependent IndividualsOther
NCT00759473D-Cycloserine Facilitation of Cocaine - Cue ExtinctionTreatment